Âðà÷ ïåðâîé êàòåãîðèè
Îêóëèñò (îôòàëüìîëîã)
Ïðèåì îò 3500
Âðà÷ ïðèíèìàåò â ñëåäóþùèõ êëèíèêàõ:
Ñòîèìîñòü ïðè¸ìà â «Îôòàëüìîëîãè÷åñêàÿ êëèíèêà Ñïåêòð»
Àäðåñ: ïð-ä Áåðåçîâîé ðîùè ä. 12
Ìåòðî: Àýðîïîðò Õîðîøåâî Çîðãå Ïàíôèëîâñêàÿ Õîðîøåâñêàÿ ÖÑÊÀ
Îáùèå ñâåäåíèÿ
- Àìáóëàòîðíûé ïðèåì, äèàãíîñòèêà è ëå÷åíèå ãëàçíîé ïàòîëîãèè;
- Ïðîâåäåíèå êîìïëåêñíîé äîïîëíèòåëüíîé äèàãíîñòèêè ïåðåä ÔÝÊ, à òàêæå ïåðåä ÝËÊ è ïîñëåîïåðàöèîîíîå âåäåíèå;
- Èíòðàâèòðåàëüíûå èíúåêöèè;
- Ëàçåðíûå ìåòîäû ëå÷åíèÿ (Ïàíðåòèíàëüíàÿ ËÊÑ, Ôîêàëüíûå ËÊÑ, Ïåðèôåðè÷åñêàÿ ËÊÑ, YAG - äèñöèçèÿ âòîðè÷íûõ ïëåí÷àòûõ êàòàðàêò);
- Èíòðàâèòðåàëüíûå èíúåêöèè (áåâàöèçóìàá, ðàíèáèçóìàá, Àôëèáåðöåïò (EYLEA);
- Õèðóðãè÷åñêèå ìåòîäû èõ ëå÷åíèå (íà÷àëüíûå ýòàïû âèòðåîðåòèíàëüíîé õèðóðãèè);
- Âûâåäåíèå ñèëèêîíà;
- Ïîâòîðíûå õèðóðãè÷åñêèå îïåðàöèè ïîñëå âèòðýêòîìèè, àññèñòåíöèÿ ïðè âèòðåîðåòèíàëüíûõ îïåðàöèÿõ;
- ÔÝÊ.
Îáðàçîâàíèå
- Äèïëîì ïî ñïåöèàëüíîñòè "Ëå÷åáíîå äåëî", Ëóãàíñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (2007 ã.)
- Èíòåðíàòóðà ïî ñïåöèàëüíîñòè "Îôòàëüìîëîãèÿ", Ëóãàíñêàÿ îáëàñòíàÿ êëèíè÷åñêàÿ áîëüíèöà (2009 ã.)
- Îðäèíàòóðà ïî ñïåöèàëüíîñòè "Îôòàëüìîëîãèÿ", Ëóãàíñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (2011 ã.)
Ïîâûøåíèå êâàëèôèêàöèè
- "3nd Low Vision awareness course, Prague", Czech Republic (2009 ã.)
- "Ëàçåðíûå ìåòîäû ëå÷åíèÿ ïàòîëîãèè ãëàçíîãî äíà", Öåíòð ìèêðîõèðóðãèè ãëàçà (2010 ã.)
- "Îñîáåííîñòè èñïîëüçîâàíèÿ ôàêîýìóëüñèôèêàòîðîâ ïðîèçâîäñòâà «Àëêîí»" (2010 ã.)
- "8th LECOP Diabetic Retinopathy Course" (2011 ã.)
- "Took observership supported by SOE Educational Grant 2011", Department of Ophthalmology at the University Medical Center Hamburg-Eppendorf (2011 ã.)
- "Dexamethasone intravitreal implant 0,7 mg Wet Lab", 11th Euretina, London (2011 ã.)
- "Was completed open Access GCP Test with an examination score of 23/25: 92% PharmaXM" (2013 ã.)
- "Èíòðàâèòðåàëüíûå è ñóáòåíîíîâûå èíúåêöèè", Èíñòèòóò ãëàçíûõ áîëåçíåé è òêàíåâîé òåðàïèè èìåíè Â. Ï. Ôèëàòîâà (2013 ã.)
- "European VitreoRetinal Training School Bremen" (2013 ã.)
- "Âèòðåîðåòèíàëüíàÿ õèðóðãèÿ" (2013 ã.)
- "Ôàêîýìóëüñèôèêàöèÿ êàòàðàêòû" (2014 ã.)
- "Intravitreal meeting at Clinic Pallas. Olten Switzerland. Bayer" (2014 ã.)
- "Îôòàëüìîëîãèÿ", Êóáàíñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (2015 ã.)
- "Îðãàíèçàöèÿ çäðàâîîõðàíåíèÿ è îáùåñòâåííîå çäîðîâüå", Êðûìñêèé ôåäåðàëüíûé óíèâåðñèòåò èìåíè Â.È. Âåðíàäñêîãî (2017 ã.)
- "Ýêñèìåðëàçåðíàÿ êîððåêöèÿ çðåíèÿ" (2017 ã.)
- "Paragon CRT for Corneal Refrective Therapy" (2018 ã.)
Ëåâàí íàïèñàëà 21.11.2024
î âðà÷å, â êëèíèêå: Îôòàëüìîëîãè÷åñêàÿ êëèíèêà Ñïåêòð
Âðà÷ ðåøèëà ìîþ ïðîáëåìó, êîòîðóþ ÿ õîòåë. Ïîëó÷èë, ÷òî òðåáîâàëîñü. Ãóäêîâà Îëüãà Àëåêñååâíà âíèìàòåëüíàÿ. Âèçèò áûë ïîëåçåí ïðîâåäåííûì îáñëåäîâàíèåì.
âðà÷:
îòíîøåíèå:
êâàëèôèêàöèÿ:
öåíà-êà÷åñòâî: